Dicyclomine hydrochloride 20 MG Oral Tablet — RxCUI 991086
RxNorm drug concept · Semantic clinical drug
RxCUI 991086
Semantic clinical drug · SCD
● Current RxNorm concept 68 FDA products
182 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI991086
Official nameDicyclomine hydrochloride 20 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdicyclomine HCl 20 MG Oral Tablet
FDA products mapped68
Package NDCs mapped182
Reported Medicaid activity (SDUD)717,408 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dicyclomine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Dicyclomine relaxes the overactive muscles in your intestines that cause IBS cramping and pain — it works both by blocking certain nerve signals and by directly calming the gut mus...
- What exactly does dicyclomine do, and how quickly will I notice it working?
- The most common ones are dizziness, dry mouth, and blurred vision — these showed up in a significant number of patients in clinical trials. You might also notice some nausea, drows...
- What are the most common side effects I should expect?
🕸️ Concept Web — How Dicyclomine hydrochloride 20 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dicyclomine hydrochloride 20 MG Oral Tablet
RxCUI 991086 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Dicyclomine
3361IN -
Dicyclomine hydrochloride
152021PIN
-
Dicyclomine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Bentyl
203018BN
-
Bentyl
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dicyclomine Oral Tablet
371817SCDF -
Dicyclomine hydrochloride Oral Tablet
2649127SCDFP -
Dicyclomine Oral Product
1151168SCDG -
Dicyclomine Pill
1151169SCDG -
Dicyclomine hydrochloride Oral Product
2659854SCDGP -
Dicyclomine hydrochloride Pill
2662305SCDGP -
Dicyclomine Oral Tablet [Bentyl]
368081SBDF -
Dicyclomine hydrochloride Oral Tablet [Bentyl]
2654863SBDFP - +5 more in this family
-
Dicyclomine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dicyclomine hydrochloride 20 MG
991085SCDC -
Dicyclomine hydrochloride 20 MG Oral Tablet [Bentyl]
991088SBD -
Dicyclomine hydrochloride 20 MG [Bentyl]
991087SBDC
-
Dicyclomine hydrochloride 20 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dicyclomine hydrochloride 20 MG
SCDC · 991085 -
Dicyclomine Oral Tablet
SCDF · 371817 -
Dicyclomine hydrochloride Oral Tablet
SCDFP · 2649127 -
Dicyclomine Oral Product
SCDG · 1151168 -
Dicyclomine Pill
SCDG · 1151169 -
Dicyclomine hydrochloride Oral Product
SCDGP · 2659854 -
Dicyclomine hydrochloride Pill
SCDGP · 2662305
Brand-Name Concepts
-
Dicyclomine hydrochloride 20 MG Oral Tablet [Bentyl]
SBD · 991088 -
Dicyclomine hydrochloride 20 MG [Bentyl]
SBDC · 991087 -
Dicyclomine Oral Tablet [Bentyl]
SBDF · 368081 -
Dicyclomine hydrochloride Oral Tablet [Bentyl]
SBDFP · 2654863 -
Bentyl Oral Product
SBDG · 1171479 -
Bentyl Pill
SBDG · 1171480 -
Bentyl
BN · 203018
📦 FDA Products & Package NDCs
68 products · 182 package NDCs
182 package NDCs map to RxCUI 991086 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 71335-2506-03 | 60 TABLET in 1 BOTTLE (71335-2506-3) | Dicyclomine Hydrochloride | Bryant Ranch Prepack | 2024-10-07 |
| 71335-2506-04 | 90 TABLET in 1 BOTTLE (71335-2506-4) | Dicyclomine Hydrochloride | Bryant Ranch Prepack | 2024-10-07 |
| 71335-2506-05 | 20 TABLET in 1 BOTTLE (71335-2506-5) | Dicyclomine Hydrochloride | Bryant Ranch Prepack | 2024-10-07 |
| 71335-2506-06 | 21 TABLET in 1 BOTTLE (71335-2506-6) | Dicyclomine Hydrochloride | Bryant Ranch Prepack | 2024-10-07 |
| 71335-2506-07 | 120 TABLET in 1 BOTTLE (71335-2506-7) | Dicyclomine Hydrochloride | Bryant Ranch Prepack | 2024-10-07 |
| 71335-2506-08 | 100 TABLET in 1 BOTTLE (71335-2506-8) | Dicyclomine Hydrochloride | Bryant Ranch Prepack | 2024-10-07 |
| 71335-2506-09 | 28 TABLET in 1 BOTTLE (71335-2506-9) | Dicyclomine Hydrochloride | Bryant Ranch Prepack | 2024-10-07 |
| 71610-0209-09 | 9000 TABLET in 1 BOTTLE (71610-209-09) | Dicyclomine Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | 2018-12-18 |
| 72162-1077-03 | 30 TABLET in 1 BOTTLE (72162-1077-3) | Dicyclomine Hydrochloride | Bryant Ranch Prepack | 2023-05-08 |
| 72162-1077-09 | 90 TABLET in 1 BOTTLE (72162-1077-9) | Dicyclomine Hydrochloride | Bryant Ranch Prepack | 2023-05-08 |
| 72162-2612-00 | 1000 TABLET in 1 BOTTLE (72162-2612-0) | Dicyclomine Hydrochloride | Bryant Ranch Prepack | 2026-04-20 |
| 72162-2612-01 | 100 TABLET in 1 BOTTLE (72162-2612-1) | Dicyclomine Hydrochloride | Bryant Ranch Prepack | 2026-04-20 |
| 72789-0466-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-466-01) | Dicyclomine hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2024-12-27 |
| 72789-0466-30 | 30 TABLET in 1 BOTTLE, PLASTIC (72789-466-30) | Dicyclomine hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2025-07-28 |
| 72789-0466-82 | 500 TABLET in 1 BOTTLE, PLASTIC (72789-466-82) | Dicyclomine hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2024-12-27 |
| 72789-0466-90 | 90 TABLET in 1 BOTTLE, PLASTIC (72789-466-90) | Dicyclomine hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2025-09-03 |
| 72789-0466-95 | 1000 TABLET in 1 BOTTLE, PLASTIC (72789-466-95) | Dicyclomine hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2024-12-27 |
| 72789-0539-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-539-01) | DICYCLOMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 2026-04-03 |
| 72789-0539-95 | 1000 TABLET in 1 BOTTLE, PLASTIC (72789-539-95) | DICYCLOMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 2026-04-03 |
| 72888-0119-00 | 1000 TABLET in 1 BOTTLE (72888-119-00) | Dicyclomine hydrochloride | Advagen Pharma Ltd., | 2022-12-14 |
| 72888-0119-01 | 100 TABLET in 1 BOTTLE (72888-119-01) | Dicyclomine hydrochloride | Advagen Pharma Ltd., | 2022-12-14 |
| 72888-0119-05 | 500 TABLET in 1 BOTTLE (72888-119-05) | Dicyclomine hydrochloride | Advagen Pharma Ltd., | 2022-12-14 |
| 72888-0119-30 | 30 TABLET in 1 BOTTLE (72888-119-30) | Dicyclomine hydrochloride | Advagen Pharma Ltd., | 2022-12-14 |
| 72888-0198-00 | 1000 TABLET in 1 BOTTLE (72888-198-00) | Dicyclomine hydrochloride | Advagen Pharma Ltd., | 2025-03-25 |
| 72888-0198-01 | 100 TABLET in 1 BOTTLE (72888-198-01) | Dicyclomine hydrochloride | Advagen Pharma Ltd., | 2025-03-25 |
| 72888-0198-05 | 500 TABLET in 1 BOTTLE (72888-198-05) | Dicyclomine hydrochloride | Advagen Pharma Ltd., | 2025-03-25 |
| 72888-0198-12 | 120 TABLET in 1 BOTTLE (72888-198-12) | Dicyclomine hydrochloride | Advagen Pharma Ltd., | 2025-03-25 |
| 72888-0198-30 | 30 TABLET in 1 BOTTLE (72888-198-30) | Dicyclomine hydrochloride | Advagen Pharma Ltd., | 2026-02-17 |
| 73473-0902-01 | 100 TABLET in 1 BOTTLE (73473-902-01) | DICYCLOMINE HYDROCHLORIDE | Solaris Pharma Corporation | 2025-06-10 |
| 73473-0902-10 | 1000 TABLET in 1 BOTTLE (73473-902-10) | DICYCLOMINE HYDROCHLORIDE | Solaris Pharma Corporation | 2025-06-10 |
| 82868-0103-30 | 30 TABLET in 1 BOTTLE, PLASTIC (82868-103-30) | Dicyclomine Hydrochloride | Northwind Health Company, LLC | 2026-03-06 |
| 87441-0007-01 | 30 TABLET in 1 BLISTER PACK (87441-007-01) | Dicyclomine Hydrochloride | Unit Dose Solutions, Inc. | 2026-06-04 |
Observed labelers:
Bryant Ranch Prepack (42) ·
A-S Medication Solutions (15) ·
NuCare Pharmaceuticals, Inc. (14) ·
PD-Rx Pharmaceuticals, Inc. (12) ·
NuCare Pharmaceuticals,Inc. (10) ·
Proficient Rx LP (10)
· +23 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.